Newsbytes
  • India
  • Business
  • World
  • Politics
  • Sports
  • Science
  • Entertainment
  • Auto
  • Lifestyle
  • Inspirational
  • Career
  • Bengaluru
  • Delhi
  • Mumbai
  • Videos
  • Find Cricket Statistics
Hindi
More
Newsbytes
Hindi
Newsbytes
User Placeholder

Hi,

Logout


India
Business
World
Politics
Sports
Science
Entertainment
Auto
Lifestyle
Inspirational
Career
Bengaluru
Delhi
Mumbai
Videos
Find Cricket Statistics

More Links
  • Videos

Download Android App

Follow us on
  • Facebook
  • Twitter
  • Linkedin
  • Youtube
 
Home / News / Business News / Sun Pharma gets warning from FDA
  • Business

    Sun Pharma gets warning from FDA

    Shiladitya Ray
    Written by
    Shiladitya Ray
    Mail
    Last updated on Dec 19, 2015, 06:27 pm
    Sun Pharma gets warning from FDA
    Credits:
  • Sun Pharmaceutical received a warning letter from the US FDA as a result of a September 2014 inspection of the company's facility at Halol, Gujarat.

    Sun responded by saying that a robust remediation process was underway with significant investments in training and automation to enhance product quality.

    The company is expected to request a re-inspection by FDA upon completion of remediation procedures.

  • In this article
    Sun Pharmaceutical's scale of operations FDA imposes import ban on Sun Pharma plant FDA announces reason for import ban The implications of Sun's inaccurate data FDA continues ban after reinspection Halol products recalled FDA pays surprise visit to Sun's Halol plant Halol plant gets relief from US FDA Sun Pharma gets warning from FDA
  • Do you know?

    Sun Pharmaceutical's scale of operations

  • After completing its acquisition of Ranbaxy for $3.2 billion in May 2015, Sun Pharmaceutical became the largest pharma company in India, the largest Indian pharma company in the US, and the 5th largest speciality generic company globally.

  • 13 Mar 2014

    FDA imposes import ban on Sun Pharma plant

    FDA imposes import ban on Sun Pharma plant
  • The US Food and Drug Administration (FDA) imposed an import ban on Sun Pharmaceutical's facility at Karkhadi, Gujarat.

    It is suspected that the ban is a result of Sun Pharmaceuticals not following Current Good Manufacturing Practice (CGMP) regulations.

    A Sun Pharma spokeswoman said that the ban on the plant would have a 'negligible' financial impact and that the company had initiated 'several corrective steps'.

  • 7 May 2014

    FDA announces reason for import ban

    FDA announces reason for import ban
    Credits:
  • In a letter dated 7th May 2014, the US FDA revealed its reason for banning imports from Sun Pharma's Karkhadi plant.

    The FDA regulator said that Sun Pharma's manufacturing staff had inadequate experience and the company failed to ensure laboratory records had complete data.

    "Your firm frequently performs 'unofficial testing' of samples, disregards the results, and reports results from additional tests," the letter read.

  • 7 May 2014

    The implications of Sun's inaccurate data

    The implications of Sun's inaccurate data
  • In the FDA's letter to Sun Pharmaceutical on 7th May 2014, serious concerns were raised about Sun's integrity of data.

    "The above examples suggest a general lack of reliability and accuracy of data generated by your firm's laboratory...raises concerns about the integrity of all data generated by your firm," the letter read.

    It was a serious issue which could result in charges of fraud.

  • 20 May 2014

    FDA continues ban after reinspection

    FDA continues ban after reinspection
  • The US Food and Drug Administration (FDA) re-inspected Sun Pharmaceutical Industries Ltd.'s Karkhadi plant in Gujarat.

    The FDA decided to continue the import ban, imposed in March 2014, on the Karkhadi plant, saying, "We have conducted a detailed review of your firm's initial response and note that it lacks sufficient corrective actions."

    Sun Pharmaceutical could not be reached for comments.

  • Do you know?

    Halol products recalled

  • Sun Pharmaceutical recalled 40,000 bottles of Venlafaxine Hydrochloride tablets after it failed the dissolution test. It also recalled Gemcitabine for manufacturing issues and Metformin for packaging problems. All three products were manufactured at the Halol plant in Gujarat.

  • 11 Sep 2014

    FDA pays surprise visit to Sun's Halol plant

    FDA pays surprise visit to Sun's Halol plant
  • The US Food and Drug Administration (FDA) conducted a surprise inspection of Sun Pharmaceutical's manufacturing facility at Halol, Gujarat.

    The inspection may have been precipitated by the fact that 3 products manufactured at Halol had recently been recalled by Sun from the US market.

    Sun Pharma refused to comment on the inspection.

    The facility contributes around 40% of Sun Pharma's US sales.

  • 27 Sep 2014

    Halol plant gets relief from US FDA

    Halol plant gets relief from US FDA
    Credits:
  • The US FDA team which conducted the inspection of the Halol plant submitted a Form 483 implying that the FDA found certain procedural lapses at the plant and would seek corrective action from Sun Pharmaceutical.

    However, to Sun Pharma's relief, the plant had 'no data integrity issues', which implied that chances of an import ban being imposed on the plant were 'low'.

  • 19 Dec 2015

    Sun Pharma gets warning from FDA

    Sun Pharma gets warning from FDA
    Credits:
  • Sun Pharmaceutical received a warning letter from the US FDA as a result of a September 2014 inspection of the company's facility at Halol, Gujarat.

    Sun responded by saying that a robust remediation process was underway with significant investments in training and automation to enhance product quality.

    The company is expected to request a re-inspection by FDA upon completion of remediation procedures.

Latest News
  • Volvo XC40 Recharge electric SUV receives first OTA software update
    Volvo XC40 Recharge electric SUV receives first OTA software update
    Auto
  • Android 11-based OxygenOS 11 update rolled out for OnePlus Nord
    Android 11-based OxygenOS 11 update rolled out for OnePlus Nord
    Science
  • Coronavirus: India's tally reaches 11.12 million with 12K+ new cases
    Coronavirus: India's tally reaches 11.12 million with 12K+ new cases
    India
  • ASUS ROG Phone 5 spotted on Geekbench with 18GB RAM
    ASUS ROG Phone 5 spotted on Geekbench with 18GB RAM
    Science
  • #DealOfTheDay: Samsung Galaxy F62 available with cashback worth Rs. 2,500
    #DealOfTheDay: Samsung Galaxy F62 available with cashback worth Rs. 2,500
    Business
Trending Topics
Bharti Airtel Mukesh Ambani WhatsApp Reliance Jio OPPO Isha Ambani
Next News Article
Share
Cancel

Want to share it with your friends too?

Facebook Whatsapp Twitter Linkedin
Copied

Love Business news?

Subscribe to stay updated.

Business Thumbnail
India News Business News World News Politics News Sports News Science News Entertainment News Auto News Lifestyle News Inspirational News
Career News Bengaluru News Delhi News Mumbai News Bharti Airtel Mukesh Ambani Indian Premier League Samsung Virat Kohli Rohit Sharma
Cricket News Narendra Modi Donald Trump YouTube Hollywood News WhatsApp Bollywood News ISRO Yoga Honda
Batman Football News Golden Globe Award BMW Vaccine Reliance Jio OPPO Food News, Healthy Recipes Royal Challengers Bangalore Toyota
Fashion Tips Mercedes Isha Ambani India Vs England Cricket OnePlus Mobiles Android TV Smart TV Marvel Comics Avengers Neha Kakkar
Premier League Big Bang Theory X-Men TATA
About Us Privacy Policy Terms & Conditions Contact Us News Reviews News Archive Topics Archive Find Cricket Statistics
Follow us on
Facebook Twitter Linkedin Youtube
All rights reserved © NewsBytes 2021